Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens.
- Resource Type
- Article
- Source
- Vaccines; Jul2022, Vol. 10 Issue 7, pN.PAG-N.PAG, 10p
- Subject
CHILD patients COVID-19 vaccines INFLAMMATORY bowel diseases IMMUNE response HUMORAL immunity - Language
- ISSN
- 2076393X